We report the multi-step synthesis of the tetradentate 2-(naphthalen-2-yl)-5-[,-bis(2-pyridylmethyl)aminomethyl]-1,3,4-oxadiazole ligand (LTetra-ODA) along with its corresponding [Fe(LTetra-ODA)(NCBH)]·1.5CHOH (C1) complex, which is the first mononuclear 1,3,4-oxadiazole based Fe(II) spin crossover (SCO) complex, and its zinc analogue [Zn(LTetra-ODA)(NCBH)]·0.5HO (C2). The spin transition is followed by variable temperature (VT-) X-ray crystallography of [Fe(LTetra-ODA)(NCBH)]·1.5CHOH (C1) at 120 and 220 K. The magnetic susceptibility measurements on the bulk sample recorded from 2 to 300 K show that the complex exhibits a complete abrupt reversible spin transition with a of 207 K. The loss of the lattice solvent methanol shifts the slightly to around 210 K. The spin transition in solution for [Fe(LTetra-ODA)(NCBH)]·1.5CHOH (C1) was followed using the VT-H-NMR Evans method in CDCN, with a of 357 K. Solid state VT luminescence studies provide some preliminary evidence of interplay of luminescence and spin transition in the [Fe(LTetra-ODA)(NCBH)]·1.5CHOH (C1) complex.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3dt02420bDOI Listing

Publication Analysis

Top Keywords

spin transition
16
[feltetra-odancbh]·15choh complex
8
spin
5
synergetic spin
4
spin singlet-quintet
4
singlet-quintet switching
4
switching luminescence
4
luminescence mononuclear
4
mononuclear feii
4
feii 134-oxadiazole
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!